These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 16857792

  • 1. Peroxisome proliferator-activated receptor gamma and growth inhibition by its ligands in uterine endometrial carcinoma.
    Ota K, Ito K, Suzuki T, Saito S, Tamura M, Hayashi S, Okamura K, Sasano H, Yaegashi N.
    Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4200-8. PubMed ID: 16857792
    [Abstract] [Full Text] [Related]

  • 2. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P, Thalhammer T, Jäger W, Aust S, Steiner G, Ensinger C, Obrist P.
    Int J Oncol; 2002 Oct 15; 21(4):915-20. PubMed ID: 12239635
    [Abstract] [Full Text] [Related]

  • 3. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY, Tseng CC.
    Mol Pharmacol; 2005 Nov 15; 68(5):1203-13. PubMed ID: 16077033
    [Abstract] [Full Text] [Related]

  • 4. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
    Takashima T, Fujiwara Y, Hamaguchi M, Sasaki E, Tominaga K, Watanabe T, Oshitani N, Higuchi K, Arakawa T.
    Oncol Rep; 2005 Apr 15; 13(4):601-6. PubMed ID: 15756430
    [Abstract] [Full Text] [Related]

  • 5. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions.
    Suzuki T, Hayashi S, Miki Y, Nakamura Y, Moriya T, Sugawara A, Ishida T, Ohuchi N, Sasano H.
    Endocr Relat Cancer; 2006 Mar 15; 13(1):233-50. PubMed ID: 16601291
    [Abstract] [Full Text] [Related]

  • 6. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS, Chen WC, Bai X, Wang YD.
    J Dig Dis; 2007 May 15; 8(2):82-8. PubMed ID: 17532820
    [Abstract] [Full Text] [Related]

  • 7. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG, Zhang ZW, Xin DQ, Shi CJ, Wu JP, Guo YL, Guan YF.
    Acta Pharmacol Sin; 2005 Jun 15; 26(6):753-61. PubMed ID: 15916743
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptor gamma is frequently underexpressed in renal cell carcinoma.
    Yuan J, Takahashi A, Masumori N, Itoh N, Tsukamoto T.
    Int J Urol; 2006 Mar 15; 13(3):265-70. PubMed ID: 16643621
    [Abstract] [Full Text] [Related]

  • 9. Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma.
    Yuan J, Takahashi A, Masumori N, Uchida K, Hisasue S, Kitamura H, Itoh N, Tsukamoto T.
    Urology; 2005 Mar 15; 65(3):594-9. PubMed ID: 15780399
    [Abstract] [Full Text] [Related]

  • 10. Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines.
    Begum NM, Nakashiro K, Kawamata H, Uchida D, Shintani S, Ikawa Y, Sato M, Hamakawa H.
    Int J Oncol; 2002 Mar 15; 20(3):599-605. PubMed ID: 11836575
    [Abstract] [Full Text] [Related]

  • 11. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
    Ward JE, Gould H, Harris T, Bonacci JV, Stewart AG.
    Br J Pharmacol; 2004 Feb 15; 141(3):517-25. PubMed ID: 14718259
    [Abstract] [Full Text] [Related]

  • 12. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R, Servidei T, Mirabella M, Rutella S, Mangiola A, Maira G, Mastrangelo R, Koeffler HP.
    Int J Oncol; 2004 Aug 15; 25(2):493-502. PubMed ID: 15254749
    [Abstract] [Full Text] [Related]

  • 13. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.
    Zang C, Liu H, Posch MG, Waechter M, Facklam M, Fenner MH, Ruthardt M, Possinger K, Phillip Koeffler H, Elstner E.
    Leuk Res; 2004 Apr 15; 28(4):387-97. PubMed ID: 15109539
    [Abstract] [Full Text] [Related]

  • 14. 15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells.
    Coyle AT, O'Keeffe MB, Kinsella BT.
    FEBS J; 2005 Sep 15; 272(18):4754-73. PubMed ID: 16156795
    [Abstract] [Full Text] [Related]

  • 15. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma.
    Eucker J, Sterz J, Krebbel H, Zavrski I, Kaiser M, Zang C, Heider U, Jakob C, Elstner E, Sezer O.
    Anticancer Drugs; 2006 Aug 15; 17(7):763-9. PubMed ID: 16926626
    [Abstract] [Full Text] [Related]

  • 16. Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats.
    Yamamoto Y, Ono T, Dhar DK, Yamanoi A, Tachibana M, Tanaka T, Nagasue N.
    J Gastroenterol Hepatol; 2008 Jun 15; 23(6):930-7. PubMed ID: 18565023
    [Abstract] [Full Text] [Related]

  • 17. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
    Han C, Demetris AJ, Michalopoulos GK, Zhan Q, Shelhamer JH, Wu T.
    Hepatology; 2003 Jul 15; 38(1):167-77. PubMed ID: 12829999
    [Abstract] [Full Text] [Related]

  • 18. 15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats.
    Zhao X, Zhang Y, Strong R, Grotta JC, Aronowski J.
    J Cereb Blood Flow Metab; 2006 Jun 15; 26(6):811-20. PubMed ID: 16208315
    [Abstract] [Full Text] [Related]

  • 19. Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells.
    Siavash H, Nikitakis NG, Sauk JJ.
    Cancer Lett; 2004 Jul 28; 211(1):97-103. PubMed ID: 15194221
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo.
    Hsu MC, Huang CC, Chang HC, Hu TH, Hung WC.
    Clin Cancer Res; 2008 Jul 01; 14(13):4045-52. PubMed ID: 18593980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.